VVVladislav P. Vasiliev

Vladislav P. Vasiliev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladislav P. Vasiliev has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Antithrombotic therapy after coronary artery bypass grafting: how to improve prognosis and preserve grafts

    by A.L. Komarov, O.O. Shakhmatova, E.E. Vlasova, T.A. Lavrikova, V.P. Vasilyev, R.S. Latypov, D.M. Galyautdinov, S.K. Kurbanov, L.M. Fedotova, E.P. Panchenko, et al.

    Antithrombotic therapy is an integral component of treatment designed to ensure long-term patency of grafts and improve prognosis in patients undergoing coronary artery bypass grafting. The authors review optimal antithrombotic treatment strategies for different categories of patients — those with stable coronary artery disease, acute coronary syndromes, concomitant atrial fibrillation, and heart valve disease. A particular attention is paid to clinical situations associated with high risk of graft failure (complex coronary reconstructions, “compromised” distal bed, coronary endarterectomy). Standard aspirin monotherapy and various options for “intensified” treatment, including addition of the second antithrombotic drug (P2Y12 receptor blocker or anticoagulant), are considered.

  • Open Access

    FACTORS DETERMINING THE ADVANTAGES OF OFF-PUMP CORONARY ARTERY BYPASS GRAFTING IN PATIENTS WITH DIFFUSE CORONARY ARTERY DISEASE

    by E.A. Borzov, R.S. Latypov, V.P. Vasiliev, E.V. Burmistrova

    АННОТАЦИЯ Цель: cравнить госпитальные исходы коронарного шунтирования (КШ) у пациентов с диффузным поражением коронарных артерий, выполненного на работающем сердце и в условиях искусственного кровообращения (ИК), для определения категорий больных, имею- щих потенциальные преимущества от операции без ИК. Материалы и методы: в рамках одноцентрового ретроспективного исследования проанализированы данные пациентов с диффузным поражением коронарного русла, перенесших КШ в период с 2020 по 2023 гг. (n=340). После проведения псевдорандомизации были сформированы две сопоставимые группы: группа 1 (n=77) – КШ на работающем сердце, группа 2 (n=77) – КШ в условиях ИК. Оценива- лись периоперационные осложнения: инфаркт миокарда (ИМ), острое нарушение мозгового кровообращения (ОНМК), выраженная дыхательная недостаточность, потребовавшая пролонгированной искусственной вентиляции легких (ИВЛ), и острая почечная недоста- точность (ОПН), требующая заместительной почечной терапии (ЗПТ). В качестве интегрального показателя использовалась комбиниро- ванная конечная точка (ККТ), включающая перечисленные события. Результаты: частота периоперационных сердечно-сосудистых событий была низкой. ИМ зарегистрирован у 2,6% и 1,3% пациентов в группах 1 и 2, соответственно (p=0,623). Случаев ОНМК в группе 1 не отмечено, в группе 2 – 1,3% (p=0,499). Выраженная дыхательная недостаточность с пролонгированной ИВЛ встречалась у 6,5% и 5,2% (p=0,742). Потребность в ЗПТ вследствие ОПН отмечена только в группе 2 (3,9%, p (для групп) =0,123). Совокупная частота ККТ составила 9,7% (n=15), демонстрируя тенденцию к увеличению в группе ИК (ОШ=2,1; 95% ДИ 0,7-6,6; p=0,277). Многофакторный анализ выявил значимое влияние мультифокального атеросклероза (ОШ=3,4; 95% ДИ 1,1-10,8; p=0,034) на риск развития ККТ, тогда как женский пол (ОШ=3,1; 95% ДИ 0,9-10,2; p=0,058) и постинфарктный кардиосклероз (ОШ=3,8; 95% ДИ 0,8-18,1; p=0,099) продемонстрировали тенденцию к ассоциации. В субанализе для пациентов высокого риска выявле- на тенденция к более благоприятным исходам при выполнении КШ на работающем сердце (ОШ=3,28, 95% ДИ 0,83–12,92, p=0,098). Заключение: проведенное исследование демонстрирует сопоставимость госпитальных исходов коронарного шунтирования на рабо- тающем сердце и в условиях ИК у пациентов с диффузным поражением коронарных артерий. При этом у больных высокого риска выявлена тенденция к преимуществу операции без ИК, что позволяет рекомендовать ее в качестве предпочтительной стратегии для данной селективной группы.

  • Long-term outcomes of simultaneous carotid endarterectomy and coronary artery bypass grafting depending on lower extremity atherosclerosis

    by D.M. Galyautdinov, E.E. Vlasova, S.K. Kurbanov, S.A. Partigulov, L.N. Ilyina, V.P. Vasiliev, O.O. Shakhmatova, A.L. Komarov, A.A. Shiryaev

    Objective. To analyze the long-term outcomes (3-7-10 years) of simultaneous carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG), mortality, incidence of cardiac and cerebral events depending on severe atherosclerotic lesions of lower limb arteries. Material and methods. The study included 156 patients (mean age 66.0±7.8 years, male/female ratio 130/26) who underwent simultaneous CEA and CABG between January 2010 and December 2022. Long-term survival was assessed in August 2023. Information was collected via telephone survey with complete data obtained for 117 (76%) patients. Patients were divided into 2 groups: group 1 — with significant lesions of lower extremity arteries (n=48), group 2 — without these lesions (n=69). The median follow-up was 57 (35;81) months. The endpoints were all-cause mortality, cardiac (recurrent angina/myocardial infarction) and cerebral (transient ischemic attack/stroke) ischemic events. Results. Both groups were comparable in baseline clinical and demographic characteristics. However, bilateral carotid lesions were more common in the 1st group (73% vs. 54%, p=0.035). There were no in-hospital differences in surgical characteristics, mortality or rate of “major” complications. However, early postoperative encephalopathy was more common in the 1st group (18% vs. 2%, p=0.008). Kaplan-Meier long-term postoperative overall survival did not differ between groups after 3 years (91% and 94%, respectively) and differed quantitatively after 7 and 10 years (70% vs. 86% and 54% vs. 72%, respectively) without statistical significance (p=0.257). Freedom from cardiac events was 82% and 94% after 3 years, 44% and 84% after 7 years, 35% and 67% after 10 years, respectively (p=0.014). Cox regression showed that atherosclerotic lesion of lower limb arteries is a significant and independent predictor of cardiac events (recurrent angina/MI) in long-term postoperative period (HR 2.67; 95% CI 1.18—6.00; p=0.017). One case of ischemic stroke was recorded in the 1st group, and no cerebral events were noted in the 2nd group. Conclusion. Atherosclerotic lesion of lower limb arteries significantly increases the risk of recurrent cardiac ischemic events in long-term period after simultaneous CEA and CABG. This fact should be taken into account when planning postoperative follow-up and secondary prevention strategies.

  • Long-term results of simultaneous carotid endarterectomy and coronary artery bypass grafting: predictors of cardiac events and mortality

    by D.M. Galyautdinov, E.E. Vlasova, S.A. Partigulov, E.A. Tabakyan, V.P. Vasiliev, L.N. Ilyina, S.K. Kurbanov, A.A. Shiryaev

    Objective. To analyze the long-term outcomes of simultaneous carotid endarterectomy (CEE) and coronary artery bypass grafting (CABG), predictors of mortality and cardiac events. Material and methods. A cohort retrospective study included 156 patients (mean age 66±8 years, male-to-female ratio 130/26) who underwent simultaneous CEE and CABG between January 2010 and December 2022. Long-term survival was assessed in August 2023. Information was collected by telephone survey, and complete data were obtained for 117 (76%) patients. Median follow-up was 57 (35; 81) months. Mortality, cardiac (angina recurrence, myocardial infarction, percutaneous coronary intervention) and cerebral events (TIA/stroke) were endpoints. Results. Long-term all-cause mortality was 16%, rate of cardiac events in long-term period — 22%. Only 1 (0.9%) ischemic stroke was diagnosed throughout the entire follow-up period. Actuarial overall survival after 3, 5 and 10 years was 93%, 86% and 65%, respectively, freedom from cardiac events — 89%, 77% and 52%, respectively. Chronic kidney disease with GFR<60 mL/min (OR 3.00; 95% CI 1.18—7.66; p=0.021) and lower extremity peripheral artery disease (OR 2.77; 95% CI 1.17—6.55; p=0.020) were significantly associated with cardiac events (recurrence of angina, myocardial infarction) in long-term period. Conclusion. Long-term all-cause mortality in patients undergoing simultaneous CEE and CABG surgery was 16%. The incidence of long-term cerebral events was very low. Chronic kidney disease with GFR<60 ml/min and lower extremity peripheral artery disease were significantly associated with long-term cardiac events.

  • Factors determining the effectiveness of various antithrombotic therapy regimens after coronary artery bypass surgery in patients with diffuse lesions and small diameter of coronary arteries: a 12-month prospective follow-up

    by T.A. Lavrikova, A.L. Komarov, E.E. Vlasova, V.P. Vasiliev, E.B. Yarovaya, E.G. Chernyshenko, S.K. Kurbanov, T.N. Veselova, S.K. Ternovoy, E.P. Panchenko, et al.

    Objective. To evaluate the factors determining prognosis within a year after coronary artery bypass grafting (CABG) in patients with diffuse lesions and/or small (<1.5mm) diameter of target arteries, as well as the effect of antithrombotic therapy (ATT) on clinical outcomes and graft occlusion. Material and methods. A single-center open prospective study included patients who underwent CABG with diffuse lesions and/or small (<1.5 mm) diameter of at least one coronary artery. This study was intended to compare different ATT regimens. Depending on therapy, patients were divided into 3 groups: ASA, ASA+C, ASA+R. Clinical outcomes were thrombotic complications in any vascular bed, recurrent angina and/or need for repeat percutaneous coronary intervention, major bleeding (BARC 2—5). Loss of bypass grafts was assessed according to CT angiography. Results. The final analysis included 201 patients. The median prospective follow-up was 12 months. There was 1 thrombotic complication (non-fatal myocardial infarction) and 3 cases of bleeding. None event led to fatal outcomes. Compared with ASA alone, any variant of multicomponent ATT was associated with lower incidence of angina recurrence and/or need for PCI (37.3 vs. 20.3%, p=0.010). The highest effects of multicomponent therapy were observed in patients without «target» LDL-C values. The incidence of angina recurrence and/or need for PCI in the ASA and ASA+C groups was 41.1 vs. 12.1% (OR=0.291), respectively, incidence of occlusion of at least one graft — 68.4% and 39.3% (OR=0.657). The incidence of occlusions of small-diameter venous grafts was significantly higher in the aspirin group compared to any variant of enhanced therapy (53.5 vs. 22.5%, p=0.0007). Conclusion. «Enhanced» ATT significantly reduces the risks of recurrent angina and/or the need for PCI, as well as the incidence of graft occlusion in patients without «target» LDL-C. «Enhanced» therapy has a protective effect on venous grafts to small (<1.5 mm) arteries.


  • Open Access

    Efficacy and safety of antiplatelet therapy intensification with clopidogrel after coronary artery bypass grafting in patients with diffuse coronary artery disease: preliminary results of a one-year study

    by T. A. Lavrikova, E. E. Vlasova, A. L. Komarov, S. K. Kurbanov, T. N. Veselova, V. P. Vasiliev, A. A. Shiryaev

    Aim. To study the clinical outcomes and the frequency of bypass graft occlusions in patients with diffuse coronary artery disease (CAD) and small (Material and methods. This prospective randomized study included 94 patients with a stable diffuse multivessel CAD with a small (Results. There were a total of 349 bypasses with a total occlusion rate of 54 (16%). The bypass occlusion rate in the ASA and ASA+clopidogrel groups was very close as follows: 19 vs 13% (p=0,191). In the subanalysis of the bypass graft function related to arteries with a diameter Conclusion. Bypass graft occlusions related to arteries of small (<1,5 mm) diameter, assessed one year after CABG, develop significantly less often with ASA+clopidogrel combination therapy.


  • In-hospital results of coronary artery bypass grafting in patients with coronary artery disease and unverified distal coronary bed

    by D.V. Petrovskii, V.P. Vasiliev, E.E. Vlasova, R.S. Latypov, D.M. Galayutdinov, A.A. Shiryaev

    Objective. To analyze in-hospital outcomes of coronary artery bypass grafting (CABG) in patients with at least one target coronary artery (CA) with unverified distal bed (UDB). Material and methods. We analyzed in-hospital outcomes of CABG in 76 patients with at least one CA with UDB between September 1, 2022 and June 30, 2024. CA with UDB was analyzed after preoperative coronary angiography (CAG). Intraoperatively, we measured diameters (d) of all coronary arteries. Some patients (n=59) underwent intraoperative transit time flowmetry (TTFM). The rule of complete myocardial revascularization was observed, except for those coronary arteries that could not be technically bypassed. Coronary artery bypass grafts were divided into two groups: bypass grafts for CA with UDB (n=89) and bypass grafts for CA with verified distal bed (VDB) (n=208). In-hospital outcomes were analyzed. Results. Only 6 out of 95 CA (6.3%) with UDB were not suitable for CABG. They were too small (n=3, 3.2%) or absent as anatomical structures (n=3, 3.2%). Other 89 (83.7%) vessels were successfully bypassed, and their diameter did not significantly differed from CA with VDB. The incidence of d<1.5 mm was similar in both groups (53.9% vs. 44.4%, p=0.15). TTFM found no significant difference in flow through bypass grafts to CA with UDB and VDB. In 1 (1.3%) patient, myocardial infarction occurred in zone corresponding to bypassed CA with VDB. Other patients had no in-hospital angina and life-threatening cardiac arrhythmias. The mortality rate was 0%. All patients were discharged after 8 [8; 10.25] days. Conclusion. Almost all CA assessed preoperatively as having UDB with preserved myocardium are intraoperatively visualized. They have sufficient diameter and anatomy for bypass grafting using microscope. Results of TTFM of bypass grafts to CA with UDB demonstrate no differences with bypass grafts to CA with VDB. In-hospital outcomes in patients with CA with UDB after CABG are satisfactory.


  • Open Access

    Myocardial revascularization in patients with coronary artery calcification: a systematic review and meta-analysis

    by R. A. Pashayev, A. A. Shiryaev, В. М. Миронов., S. K. Kurbanov, E. E. Vlasova, K. G. Ganayev, G. M. Kurbanov, A. V. Andreyev, V. P. Vasilyev, D. M. Galyautdinov, et al.

    Aim. To analyze and generalize inhospital outcomes of myocardial revascularization in patients with coronary artery calcification.Material and methods. The primary selection yielded 470 publications, including 354 from the Pubmed database in English and 116 from the E-library database in Russian. Thirteen studies were selected that met the search criteria. Among them, 5 studies were for coronary artery bypass grafting (n=932) and 8 for endovascular intervention (n=5758). The endpoints were 30-day mortality and perioperative myocardial infarction (PMI).Results. PMI incidence in patients with coronary artery calcification in percutaneous coronary intervention using atherectomy techniques is 4,4%, while inhospital mortality - 0,9%. PMI incidence in coronary artery bypass grafting using complex coronary interventions in this group of patients is 2,6%, while inhospital mortality - 0,7%.Conclusion. Myocardial revascularization in patients with coronary calcification can be performed by endovascular and open approaches using advanced coronary surgery techniques. Inhospital outcomes seem satisfactory. Conclusions about the advantages of one method or another require comparative studies.


  • Long-term results of isolated coronary artery bypass surgery in patients with concomitant carotid artery stenosis

    by D.M. Galyautdinov, E.E. Vlasova, A.A. Shiryaev, S.A. Partigulov, V.P. Vasiliev, S.K. Kurbanov, R.S. Akchurin

    OBJECTIVE To analyze long-term mortality, incidence of cerebral and cardiac events after isolated coronary bypass grafting (CABG) in patients with concomitant lesions of coronary and carotid arteries, to determine the factors associated with long-term mortality. MATERIAL AND METHODS There were 249 patients (mean age 64±6.5 years, male-to-female ratio 188/61). All ones had multiple-vessel coronary artery disease and stenosis of at least one internal carotid artery ≥50% and underwent isolated CABG in 2010—2019. In 130 patients, ICA stenosis was 50—60%, in 84 patients — 65—70%, in 27 — >70%, in 8 — ICA occlusion. All patients received aspirin, statins and β-blockers after CABG. Overall and cardiac mortality, incidence of cerebral and cardiac events were assessed in long-term period. The median follow-up was 76 [56; 112] months. Pre-, intra- and postoperative factors (n=28) were studied as potential predictors of overall mortality. RESULTS All-cause long-term mortality was 13.2% (33/249), cardiac mortality — 6.8% (17/249). Delayed cerebral events developed in 17 (6.8%) patients: 3 ones had transient ischemic attack on the side of lesion in 3, 5 and 7 years after surgery, 14 ones had stroke (unilateral in 12 cases within 1-9 years, 2 cases were fatal). The next cardiac events were registered throughout the follow-up period: angina recurrence — in 46 (18.5%), myocardial infarction (MI) — in 5 (2.0%). Fifteen (6.0%) patients underwent percutaneous coronary interventions, and other ones received medicines. Univariate analysis revealed the following factors associated with long-term overall mortality: chronic heart failure (CHF) with reduced left ventricular ejection fraction (LVEF) p=0.015), postoperative atrial fibrillation (AF) (OR 2.7; 95% CI 1.2—5.9; p=0.012) and previous MI (OR 2.3; 95% CI 1.1—5.2; p=0.031). Multivariate analysis confirmed the effect of CHF with LVEF p=0.041) and AF in postoperative period (OR 2.4; 95% CI 1.0—5.9; p=0.049), as well as revealed another factor affecting long-term overall mortality, i.e. chronic obstructive pulmonary disease (COPD) (OR 2.8; 95% CI 1.0—7.7; p=0.045). CONCLUSION In patients with multiple-vessel coronary and carotid lesions undergoing isolated CABG, all-cause long-term mortality was 13.2% (33/249). Incidence of delayed cerebral events (6.8%) and their predominant unilateral nature indicate the need for careful cerebrovascular monitoring after CABG. CHF with LVEF <40%, postoperative AF, previous MI and COPD are associated with higher all-cause long-term mortality.